Big apple-based biotech’s new gene therapy subsidiary inks UNC licensing deals
December 05, 2017 at 13:53 PM EST
New York-based Fortress Biotech has formed a new gene therapy subsidiary. And as part of that formation, it has inked three exclusive licensing agreements with UNC-Chapel Hill.
